Bosh sahifaSHTDY • OTCMKTS
add
Sinopharm Group ADR
Yopilish kursi
12,22 $
Kunlik diapazon
12,75 $ - 13,08 $
Yillik diapazon
10,13 $ - 16,31 $
Bozor kapitalizatsiyasi
63,19 mlrd HKD
Oʻrtacha hajm
44,99 ming
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | -122,51 mlrd | -0,93% |
Joriy xarajat | -6,47 mlrd | -5,44% |
Sof foyda | -419,63 mln | 30,73% |
Sof foyda marjasi | 0,34 | -32,00% |
Har bir ulushga tushum | — | — |
EBITDA | -2,33 mlrd | 20,26% |
Amaldagi soliq stavkasi | 26,07% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 8,62 mlrd | -74,94% |
Jami aktivlari | 33,55 mlrd | -91,97% |
Jami passivlari | 15,61 mlrd | -94,87% |
Umumiy kapital | 17,94 mlrd | — |
Tarqatilgan aksiyalar | 3,12 mlrd | — |
Narxi/balansdagi bahosi | 2,36 | — |
Aktivlardan daromad | -2,64% | — |
Kapitaldan daromad | -5,30% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -419,63 mln | 30,73% |
Operatsiyalardan naqd pul | 46,42 mlrd | 14,53% |
Sarmoyadan naqd pul | -362,06 mln | 22,79% |
Moliyadan naqd pul | -23,30 mlrd | -6,05% |
Naqd pulning sof oʻzgarishi | 22,75 mlrd | 25,76% |
Boʻsh pul | 103,16 mlrd | 370,65% |
Haqida
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Tashkil etilgan
2003
Sayt
Xodimlar soni
113 635
